Your browser is no longer supported. Please, upgrade your browser.
Settings
GNCA Genocea Biosciences, Inc. daily Stock Chart
GNCA [NASD]
Genocea Biosciences, Inc.
Index- P/E- EPS (ttm)-2.27 Insider Own12.35% Shs Outstand25.96M Perf Week13.70%
Market Cap43.09M Forward P/E- EPS next Y-1.33 Insider Trans0.00% Shs Float24.23M Perf Month-7.26%
Income-39.00M PEG- EPS next Q-0.35 Inst Own54.80% Short Float1.32% Perf Quarter-23.85%
Sales- P/S- EPS this Y30.00% Inst Trans2.74% Short Ratio1.11 Perf Half Y-48.77%
Book/sh0.88 P/B1.89 EPS next Y2.20% ROA-71.30% Target Price16.40 Perf Year-65.70%
Cash/sh1.54 P/C1.07 EPS next 5Y- ROE-158.50% 52W Range1.10 - 11.28 Perf YTD-19.81%
Dividend- P/FCF- EPS past 5Y36.40% ROI- 52W High-85.28% Beta2.28
Dividend %- Quick Ratio6.60 Sales past 5Y- Gross Margin- 52W Low50.91% ATR0.22
Employees59 Current Ratio6.60 Sales Q/Q- Oper. Margin- RSI (14)47.25 Volatility9.26% 15.17%
OptionableYes Debt/Eq0.55 EPS Q/Q- Profit Margin- Rel Volume0.21 Prev Close1.56
ShortableYes LT Debt/Eq0.55 EarningsFeb 13 BMO Payout- Avg Volume287.59K Price1.66
Recom1.40 SMA20-3.54% SMA50-16.63% SMA200-39.29% Volume59,895 Change6.41%
Nov-15-19Initiated SVB Leerink Outperform $7
Jul-08-19Resumed Stifel Buy $13
Mar-01-19Reiterated Needham Buy
Feb-06-18Upgrade Needham Hold → Buy $3
Sep-27-17Downgrade Needham Buy → Hold
Sep-26-17Downgrade Stifel Buy → Hold $15 → $2.50
Jul-25-17Upgrade Needham Hold → Buy $12
Feb-17-17Downgrade Needham Buy → Hold
Apr-01-16Reiterated Stifel Buy $11 → $13
Dec-17-15Initiated UBS Buy $15
Oct-20-15Reiterated Needham Buy $22 → $15
Oct-19-15Reiterated FBR Capital Outperform $20 → $17
Mar-05-14Initiated Needham Buy $22
Mar-03-14Initiated Stifel Buy $25
Feb-26-20 04:05PM  Genocea to Present at the Cowen & Company 40th Annual Health Care Conference GlobeNewswire
Feb-20-20 09:15PM  Edited Transcript of GNCA earnings conference call or presentation 13-Feb-20 1:30pm GMT Thomson Reuters StreetEvents
08:00AM  Genocea to Present at the SVB Leerink 9th Annual Global Healthcare Conference GlobeNewswire
Feb-13-20 07:00AM  Genocea Provides Fourth Quarter 2019 Corporate Update GlobeNewswire
Feb-06-20 07:30AM  Genocea to Host Fourth Quarter 2019 Corporate Update Conference Call & Webcast GlobeNewswire
Dec-14-19 09:43PM  Genocea Biosciences Inc (GNCA): Hedge Fund Sentiment Unchanged Insider Monkey
Nov-14-19 05:00PM  Genocea to Present at the Stifel 2019 Healthcare Conference GlobeNewswire +9.27%
08:30AM  Genocea Biosciences Enters Oversold Territory Zacks
Nov-09-19 09:00AM  Genocea Preclinical Data at SITC Demonstrate that Inhibitory Neoantigens in an Otherwise Protective Vaccine Reverse Anti-Tumor Responses GlobeNewswire
Nov-05-19 08:05AM  Genocea Presents Preclinical Research that Shows Inhibitory Neoantigens Stifle Protective Anti-Tumor Immune Responses at Society for Immunotherapy of Cancer (SITC) GlobeNewswire
Oct-29-19 07:22AM  Edited Transcript of GNCA earnings conference call or presentation 24-Oct-19 12:30pm GMT Thomson Reuters StreetEvents
Oct-24-19 07:00AM  Genocea Provides Corporate Update and Reports Third Quarter 2019 Financial Results GlobeNewswire -6.49%
Oct-17-19 08:00AM  Genocea to Host Third Quarter 2019 Corporate Update Conference Call & Webcast GlobeNewswire
Sep-30-19 01:13PM  Movers And Shakers At ESMO 2019: Immunomedics, G1 Therapeutics, Seattle Genetics And More Benzinga -5.84%
Sep-27-19 08:00AM  Genocea Announces Poster Presentation at The European Society for Medical Oncology (ESMO) Congress 2019 in Barcelona and Presentation at an Upcoming Investor Conference GlobeNewswire
Sep-18-19 09:31AM  Buy These 7 Small Drugmakers to Boost Your Portfolio's Health Zacks
Aug-30-19 08:00AM  Genocea to Present at September Healthcare Conferences GlobeNewswire
Aug-24-19 01:46PM  10 Biopharmaceutical Companies Trying To Cure Cancer Benzinga
Aug-05-19 01:13PM  Edited Transcript of GNCA earnings conference call or presentation 25-Jul-19 12:30pm GMT Thomson Reuters StreetEvents
Jul-25-19 07:00AM  Genocea Provides Corporate Update, Including Second-Quarter 2019 Financial Results GlobeNewswire -7.24%
Jul-18-19 08:00AM  Genocea to Host Quarterly Corporate Update Conference Call & Webcast on July 25th at 8:30 am ET GlobeNewswire
Jun-25-19 08:37AM  Penny Stocks to Buy Using Technical Analysis for June 2019 Investopedia
Jun-24-19 01:58PM  Need To Know: Genocea Biosciences, Inc. (NASDAQ:GNCA) Insiders Have Been Buying Shares Simply Wall St. +5.19%
Jun-20-19 09:52AM  Are Options Traders Betting on a Big Move in Genocea Biosciences (GNCA) Stock? Zacks -7.79%
Jun-18-19 04:04PM  Genocea Announces Proposed Public Offering of Common Stock GlobeNewswire
Jun-03-19 12:47PM  Genocea Biosciences Rallies 50% On ASCO Presentation Benzinga +19.61%
10:45AM  Put Buyers Blast Red-Hot Genocea Biosciences Stock Schaeffer's Investment Research
09:17AM  Genocea Biosciences shares rocket 101% after biotech announces positive data from early-stage trial of cancer vaccine MarketWatch
07:00AM  Genoceas GEN-009 Vaccine Demonstrates Best-in-Class Immune Responses to ATLAS-selected Neoantigens in Cancer Patients GlobeNewswire
May-31-19 12:44PM  The Genocea Biosciences (NASDAQ:GNCA) Share Price Is Down 97% So Some Shareholders Are Very Salty Simply Wall St. +24.67%
08:00AM  Genoceas GEN-009 Clinical Results Presentation Selected by ASCOs Journal of Clinical Oncology® as a Top 10 Featured Immuno-oncology Abstract GlobeNewswire
May-23-19 05:34PM  Edited Transcript of GNCA earnings conference call or presentation 30-Apr-19 1:00pm GMT Thomson Reuters StreetEvents
May-16-19 01:00PM  Genocea Announces Research Collaboration with Iovance to Explore Development of Neoantigen-Targeted TIL (Tumor-Infiltrating Lymphocyte) Products GlobeNewswire
08:00AM  Genocea Announces Positive Interim Immunogenicity Data from GEN-009 Neoantigen Vaccine Phase 1/2a Clinical Trial GlobeNewswire
Apr-30-19 08:13AM  Genocea Biosciences: 1Q Earnings Snapshot Associated Press -7.88%
08:00AM  Genocea Provides Corporate Update, Including First-Quarter 2019 Financial Results GlobeNewswire
Apr-23-19 08:00AM  Genocea to Host Quarterly Corporate Update Conference Call & Webcast on April 30th at 9:00 am ET GlobeNewswire
Apr-03-19 04:01PM  Genocea to Present at 18th Annual Needham Healthcare Conference GlobeNewswire +9.57%
Apr-02-19 01:00PM  Genocea Presents Data at AACR 2019 Supporting Utility of ATLAS Platform in Predicting Melanoma Patient Response to Immune Checkpoint Inhibitors GlobeNewswire
Mar-20-19 10:38AM  Top Ranked Momentum Stocks to Buy for March 20th Zacks
Mar-19-19 11:52AM  Edited Transcript of GNCA earnings conference call or presentation 28-Feb-19 2:00pm GMT Thomson Reuters StreetEvents
Mar-13-19 08:23AM  Will Genocea Biosciences Continue to Surge Higher? Zacks
Mar-07-19 08:18AM  Top Ranked Momentum Stocks to Buy for March 7th Zacks
Mar-06-19 08:05AM  Genocea to Present at the Cowen & Company 39th Annual Health Care Conference GlobeNewswire -5.71%
Feb-28-19 08:00AM  Genocea Reports Fourth Quarter 2018 Results and Announces Hiring of New Chief Financial Officer GlobeNewswire -18.89%
Feb-21-19 08:00AM  Genocea to Host Quarterly Corporate Update Conference Call & Webcast on February 28 at 9:00 am ET GlobeNewswire +6.84%
Feb-12-19 08:30AM  Genocea Announces Private Placement Financing of Up to $39 Million GlobeNewswire +8.21%
Jan-30-19 02:21PM  How Does Investing In Genocea Biosciences, Inc. (NASDAQ:GNCA) Impact The Volatility Of Your Portfolio? Simply Wall St. +12.50%
Jan-02-19 11:55AM  These 4 Healthcare Stocks Are Kicking Off The New Year With A Bang ACCESSWIRE +46.44%
08:00AM  Genocea Doses First Patients and Completes Enrollment in Part A of Phase 1/2a Clinical Trial for Neoantigen Vaccine Candidate GEN-009 GlobeNewswire
Dec-14-18 12:14PM  Read This Before Selling Genocea Biosciences, Inc. (NASDAQ:GNCA) Shares Simply Wall St.
Dec-10-18 08:00AM  Genocea Appoints Girish Aakalu, Ph.D., Chief Business Officer GlobeNewswire
Nov-27-18 08:40AM  Detailed Research: Economic Perspectives on Genocea Biosciences, Big Lots, SemGroup, Conn's, Mimecast, and Neos Therapeutics What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-15-18 08:00AM  Genocea To Host a Key Opinion Leader Event November 26th on Latest Advances in Personalized Cancer Immunotherapies GlobeNewswire
Nov-06-18 07:10PM  Edited Transcript of GNCA earnings conference call or presentation 1-Nov-18 1:00pm GMT Thomson Reuters StreetEvents
08:00AM  Genocea Unveils Possible Mechanism for Tumor Resistance to Immunotherapy at Society for Immunotherapy of Cancers (SITC) 33rd Annual Meeting GlobeNewswire
Nov-01-18 08:35AM  Genocea Biosciences: 3Q Earnings Snapshot Associated Press
08:00AM  Genocea Reports Third Quarter 2018 Financial and Operating Results GlobeNewswire
Oct-25-18 08:05AM  Genocea to Host Third Quarter 2018 Financial Results Conference Call & Webcast on November 1, 2018 at 9:00 a.m. ET GlobeNewswire
Oct-19-18 03:07PM  Do Institutions Own Shares In Genocea Biosciences Inc (NASDAQ:GNCA)? Simply Wall St.
Oct-11-18 08:35AM  Analysis: Positioning to Benefit within Genocea Biosciences, Retail Properties of America, Hawkins, QUANTENNA COMMS, Hillenbrand, and Herman Miller Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Oct-09-18 08:35AM  Genocea Announces Upcoming Presentations at SITC 2018 GlobeNewswire
Oct-01-18 07:30AM  Genocea Strengthens Leadership Team: Thomas Davis, M.D. Appointed Chief Medical Officer; Derek Meisner, J.D. Joins as General Counsel GlobeNewswire
Sep-24-18 08:02AM  Genocea to Present at Two October Investor Conferences GlobeNewswire +10.91%
Aug-29-18 08:05AM  Genocea to Present at Two September Investor Conferences GlobeNewswire
Aug-16-18 05:41AM  Genocea Biosciences Sees Hammer Chart Pattern: Time to Buy? Zacks +5.80%
Aug-07-18 07:35AM  Consolidated Research: 2018 Summary Expectations for Genocea Biosciences, Hawkins, Landstar System, American Assets Trust, TriCo Bancshares, and LogMein Fundamental Analysis, Key Performance Indications GlobeNewswire
Aug-02-18 03:18PM  Edited Transcript of GNCA earnings conference call or presentation 2-Aug-18 1:00pm GMT Thomson Reuters StreetEvents +14.53%
09:58AM  Genocea Biosciences: 2Q Earnings Snapshot Associated Press
08:04AM  Genocea Reports Second Quarter 2018 Financial and Operating Results GlobeNewswire
07:00AM  Genocea Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Jul-26-18 08:05AM  Genocea to Host Second Quarter 2018 Financial Results Conference Call & Webcast on August 2, 2018 at 9:00 a.m. ET GlobeNewswire
Jul-11-18 07:35AM  Complimentary Technical Snapshots on Incyte and Three More Biotech Stocks ACCESSWIRE
Jun-01-18 08:04AM  Genocea to Present at Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-10-18 09:02AM  Genocea Biosciences: 1Q Earnings Snapshot Associated Press
07:59AM  Genocea Reports First Quarter 2018 Financial and Operating Results GlobeNewswire
May-04-18 08:04AM  Genocea to Host First Quarter 2018 Financial Results Conference Call & Webcast on May 10, 2018 at 9 a.m. ET GlobeNewswire
May-02-18 07:45AM  Market Trends Toward New Normal in City Office REIT, Malibu Boats, Vical, Renasant, Genocea Biosciences, and Lindsay Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire +7.21%
Apr-30-18 08:04AM  Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009 GlobeNewswire
Apr-18-18 09:01AM  Genocea Presents Data at AACR Annual Meeting Further Highlighting Advantages of ATLAS Platform in Identification of Neoantigens over in silico Methods GlobeNewswire
Apr-09-18 08:05AM  Genocea to Present Data at Upcoming AACR Annual Meeting Further Highlighting ATLAS Platform Ability to Identify and Characterize Neoantigens for Cancer Vaccines GlobeNewswire
Mar-27-18 05:23AM  Genocea Biosciences a Good Buy and Hold Stock FX Empire -7.89%
Mar-12-18 05:39PM  Genocea Appoints Narinder Singh as SVP Pharmaceutical Sciences & Manufacturing GlobeNewswire
Mar-08-18 03:23PM  HC Wainwright Takes Bullish Stance On Two Cancer-Focused Pharma Companies Benzinga
Mar-05-18 08:00AM  Genocea to Present at Two March Investor Conferences GlobeNewswire
Mar-02-18 07:30AM  Research Report Identifies AutoZone, Highwoods Properties, Virtu Financial, Genocea Biosciences, LGI Homes, and Agios Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-23-18 05:13PM  Genocea Biosciences Inc (NASDAQ:GNCA): Does The -14.40% Earnings Decline Make It An Underperformer? Simply Wall St.
Feb-15-18 08:33AM  Genocea Biosciences reports 4Q loss Associated Press
08:00AM  Genocea Reports Fourth Quarter and Full-Year 2017 Financial Results GlobeNewswire
06:50AM  Genocea Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Feb-12-18 04:01PM  NEA Partner Ali Behbahani, M.D. Joins Genocea Biosciences Board of Directors GlobeNewswire
Feb-08-18 08:00AM  Genocea to Host Fourth Quarter and Year End 2017 Financial Results Conference Call & Webcast on February 15, 2018 at 9 a.m. ET GlobeNewswire
Jan-17-18 08:40AM  Genocea Biosciences, Inc. Announces Pricing of $55 Million Concurrent Public Offerings GlobeNewswire
Jan-16-18 04:01PM  Genocea Biosciences, Inc. Announces Proposed Concurrent Public Offerings of Common Stock and Class A Warrants and Series A Convertible Preferred Stock and Class A Warrants GlobeNewswire
Jan-08-18 07:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Kelly Services, Genocea Biosciences, Balchem, Federal Signal, Marriott Vacations Worldwide, and International Bancshares New Research Emphasizes Economic Growth GlobeNewswire
Jan-03-18 09:58AM  How Do Analysts See Genocea Biosciences Inc (NASDAQ:GNCA) Performing Over The Couple Of Years? Simply Wall St.
Jan-02-18 02:54PM  Glancy Prongay & Murray Reminds Investors of the January 2, 2018 Deadline in the Class Action Lawsuit Against Genocea Biosciences, Inc. (GNCA) Business Wire
Dec-28-17 01:41PM  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Genocea Biosciences, Inc. Shareholders and a Lead Plaintiff Deadline of January 2, 2018 ACCESSWIRE
Dec-27-17 08:35PM  Robbins Arroyo LLP: Genocea Biosciences, Inc. (GNCA) Misled Shareholders According to a Recently Filed Class Action Business Wire
04:54PM  GENOCEA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 In Genocea Biosciences, Inc. To Contact The Firm Business Wire
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, to profile patient's CD4+ and CD8+ T cell immune responses to potential target or antigen in that patient's tumor. It develops immuno-oncology programs, such as GEN-009, an adjuvanted neoantigen peptide vaccine candidate, which is in the phase I/IIa clinical trial; GEN-011, a neoantigen adoptive T cell therapy program; and GEN-010, a neoantigen vaccine program. Genocea Biosciences, Inc. was founded in 2006 and is based in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sonsini Peter W.10% OwnerJun 24Buy3.502,857,1429,999,9977,225,676Jun 25 04:52 PM
MAKOWER JOSHUA10% OwnerJun 24Buy3.502,857,1429,999,9977,225,676Jun 25 04:51 PM
MOTT DAVID M10% OwnerJun 24Buy3.502,857,1429,999,9977,225,676Jun 25 04:51 PM
SANDELL SCOTT D10% OwnerJun 24Buy3.502,857,1429,999,9977,225,676Jun 25 04:52 PM
Chang Carmen10% OwnerJun 24Buy3.502,857,1429,999,9977,225,676Jun 25 04:50 PM
Florence Anthony A. Jr.10% OwnerJun 24Buy3.502,857,1429,999,9977,225,676Jun 25 04:50 PM
Makhzoumi Mohamad10% OwnerJun 24Buy3.502,857,1429,999,9977,225,676Jun 25 04:50 PM
BASKETT FOREST10% OwnerJun 24Buy3.502,857,1429,999,9977,225,676Jun 25 04:49 PM
Behbahani AliDirectorJun 24Buy3.502,857,1429,999,9977,225,676Jun 25 04:49 PM
New Enterprise Associates 16, 10% OwnerJun 24Buy3.502,857,1429,999,9977,225,676Jun 25 04:48 PM
BARRIS PETER J10% OwnerJun 24Buy3.502,857,1429,999,9977,225,676Jun 25 04:48 PM
GLAXOSMITHKLINE PLC10% OwnerJun 24Buy3.501,857,1426,499,9973,365,884Jun 26 10:46 AM
Singh NarinderjeetSENIOR VP, PS&MMay 08Option Exercise0.547,2913,93761,873May 09 12:55 PM
Singh NarinderjeetSENIOR VP, PS&MApr 11Option Exercise0.547,2913,93754,582Apr 12 12:11 PM